Skip to content

Homoeopathic treatment of Seborrheic Dermatitis with Sanicula Aqua

To study the therapeutic role of Sanicula Aqua in cases of Seborrheic Dermatitis assessed by using SDASI score: A prospective interventional study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/05/086325
Enrollment
40
Registered
2025-05-05
Start date
Unknown
Completion date
Unknown
Last updated
2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L219- Seborrheic dermatitis, unspecified

Interventions

Intervention1: Sanicula Aqua: Sanicula Aqua Homoeopathic medicine in selective potency as in as in required repetition for 15 days Control Intervention1: NOT APPLICABLE, as there is no comparator agen

Sponsors

Harisha Rohit
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. All clinically diagnosed instances of Seborrheic Dermatitis and has family 2. History of Seborrheic dermatitis, regardless of sex, socioeconomic level, ethnicity, or occupation. 3. Individuals with symptoms similar to Sanicula Aqua. 4. Those who are willing to give consent.

Exclusion criteria

Exclusion criteria: 1. Complications in cases such as sebo-psoriasis, candidiasis etc. 2. Individuals with immunocompromised cases such as HIV, Lymphoma etc. 3. Pregnant women and lactating mother. 4. Patient taking other modes of treatment for Seborrheic Dermatitis.

Design outcomes

Secondary

MeasureTime frame
The severity and treatment outcome will be assessed using the Seborrheic Dermatitis Area and Severity IndexTimepoint: 6 months

Primary

MeasureTime frame
Betterment in health of patientTimepoint: 6 Months

Countries

India

Contacts

Public ContactDr Munjal Thakar

Jawaharlal Nehru Homoeopathic Medical College and Hospital

gaurav.sharma18479@paruluniversity.ac.in9824372731

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026